A multi-center, parallel group, flexible dose trial with a double-blind, randomized, placebo-controlled phase followed by an open-label phase to assess the impact of Viagra [sildenafil] on the sexual satisfaction of men with mild erectile dysfunction

Trial Profile

A multi-center, parallel group, flexible dose trial with a double-blind, randomized, placebo-controlled phase followed by an open-label phase to assess the impact of Viagra [sildenafil] on the sexual satisfaction of men with mild erectile dysfunction

Completed
Phase of Trial: Phase IV

Latest Information Update: 06 Apr 2017

At a glance

  • Drugs Sildenafil (Primary)
  • Indications Erectile dysfunction
  • Focus Therapeutic Use
  • Sponsors Pfizer
  • Most Recent Events

    • 08 Oct 2008 Actual patient number (183) added as reported by ClinicalTrials.gov.
    • 07 Jun 2007 Status changed from recruiting to in progress.
    • 15 Oct 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top